Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Medipharm Labs Corp (LABS.TO)

Medipharm Labs Corp (LABS.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 28,775
  • Shares Outstanding, K 411,070
  • Annual Sales, $ 33,062 K
  • Annual Income, $ -13,083 K
  • EBIT $ N/A
  • EBITDA $ N/A
  • 60-Month Beta 1.12
  • Price/Sales 0.74
  • Price/Cash Flow N/A
  • Price/Book 0.60
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm -0.04
  • Most Recent Earnings $-0.01 on 08/14/24
  • Next Earnings Date 11/12/24
  • Annual Dividend & Yield N/A (N/A)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.0650 +7.69%
on 10/07/24
0.0800 -12.50%
on 10/28/24
unch (unch)
since 10/01/24
3-Month
0.0600 +16.67%
on 09/16/24
0.0800 -12.50%
on 10/28/24
+0.0050 (+7.69%)
since 08/01/24
52-Week
0.0600 +16.67%
on 09/16/24
0.1000 -30.00%
on 03/26/24
unch (unch)
since 11/01/23

Most Recent Stories

More News
MediPharm Labs Announces Departure of President and Co-Founder Keith Strachan

/CNW/ - MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) ("MediPharm", "MediPharm Labs" or the "Company"), a specialized, research-driven company focused on...

MEDIF : 0.0531 (+2.12%)
LABS.TO : 0.0700 (unch)
Stocks in play: MediPharm Labs Corp.

Announced that it has paid off the entire remaining convertible debt amount of $2.1 million, leaving ...

LABS.TO : 0.0700 (unch)
MediPharm Labs Announces $2.1M Debt Repayment

/CNW/ - MediPharm Labs Corp. ("MediPharm" or the "Company") (TSX: LABS), a specialized, research-driven pharmaceutical company focused on cannabis-based health...

LABS.TO : 0.0700 (unch)
Stocks in play: MediPharm Labs Corp.

Announced its financial results for the three months ended June 30, 2024. Adjusted EBITDA proved negative ...

LABS.TO : 0.0700 (unch)
MediPharm Labs Reports Second Quarter Results Closing in on Positive Adjusted EBITDA(1) as Gross Profit Continues to Improve

/CNW/ - MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) ("MediPharm", "MediPharm Labs" or the "Company") a pharmaceutical company specialized in...

MEDIF : 0.0531 (+2.12%)
LABS.TO : 0.0700 (unch)
/R E P E A T -- MediPharm Labs Sets Date to Report Second Quarter 2024 Financial Results/

/CNW/ - MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) ("MediPharm", "MediPharm Labs" or the "Company") a pharmaceutical company specialized in...

MEDIF : 0.0531 (+2.12%)
LABS.TO : 0.0700 (unch)
MediPharm Labs Sets Date to Report Second Quarter 2024 Financial Results

/CNW/ - MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) ("MediPharm", "MediPharm Labs" or the "Company") a pharmaceutical company specialized in...

MEDIF : 0.0531 (+2.12%)
LABS.TO : 0.0700 (unch)
Stocks in play: MediPharm Labs Corp.

Announced it has entered into a licencing agreement with Remidose Aerosols Inc. to acquire the exclusive ...

LABS.TO : 0.0700 (unch)
MediPharm Labs Announces Voting Results From the 2024 Annual Meeting of Shareholders

/CNW/ - MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ) ("MediPharm", "MediPharm Labs" or the "Company"), a pharmaceutical company specialized in...

MEDIF : 0.0531 (+2.12%)
LABS.TO : 0.0700 (unch)
Stocks in play: MediPharm Labs Corp.

Announced it has entered into a licencing agreement with Remidose Aerosols Inc. to acquire the exclusive ...

LABS.TO : 0.0700 (unch)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Sell with a Weakest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

MediPharm Labs Corp is a pharmaceutical company specializing in precision-based cannabinoids. The Company operates in one reportable segment, the production and sales of cannabis flower, extracts, and derivative products. Through its wholesale and white-label platforms, MediPharm Labs formulates, develops,...

See More

Key Turning Points

3rd Resistance Point 0.0783
2nd Resistance Point 0.0767
1st Resistance Point 0.0733
Last Price 0.0700
1st Support Level 0.0683
2nd Support Level 0.0667
3rd Support Level 0.0633

See More

52-Week High 0.1000
Fibonacci 61.8% 0.0847
Fibonacci 50% 0.0800
Fibonacci 38.2% 0.0753
Last Price 0.0700
52-Week Low 0.0600

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar